Why the study?
Does standard-dose rivaroxaban maintain efficacy and safety compared to standard treatment in adult patients across different weight and body mass index categories?
Does standard-dose rivaroxaban maintain efficacy and safety compared to standard treatment in adult patients across different weight and body mass index categories?
Standard-dose rivaroxaban can be safely prescribed in adult patients of all weights without the need for dose adjustment.
Authors
No takes yet. Share an insight, caveat, or question.
Supports standard rivaroxaban dosing across weights; leaves open dedicated prospective validation in extreme BMI.
James Uprichard (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: